Skip to main content
. 2017 Mar 21;6(1):29–31. doi: 10.14740/jh322e

Table 1. Published Treatment Regimens and Outcomes for MM-Induced Hyperammonemic Encephalopathy.

Treatment Outcome
Bortezomib + cyclophosphamide + dexamethasone [11] Patient released home after 11 days.
Bortezomib + high dose dexamethasone + bendamustine [6] Patient died 2 weeks after treatment due to aspiration pneumonia.
Simultaneous continuous venovenous hemodialysis and extended daily hemodialysis
Vincristine + high dose dexamethasone [12]
Patient with medically refractory hyperammonemia survived and was discharged home.